These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15855530)

  • 21. Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytes.
    Niu C; Murakami E; Furman PA
    Antivir Ther; 2008; 13(2):263-9. PubMed ID: 18505177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.
    Feinberg A; Vidal PM; Fox JJ; Watanabe KA; Chun MW; Field FH; Bencsath A; Chait B; Philips FS
    Drug Metab Dispos; 1984; 12(6):784-6. PubMed ID: 6150831
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
    Cheng YC; Dutschman G; Fox JJ; Watanabe KA; Machida H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):420-3. PubMed ID: 6272634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural requirements for efficient phosphorylation of nucleotide analogs by human thymidylate kinase.
    Lavie A; Konrad M
    Mini Rev Med Chem; 2004 May; 4(4):351-9. PubMed ID: 15134538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Yao GQ; Liu SH; Chou E; Kukhanova M; Chu CK; Cheng YC
    Biochem Pharmacol; 1996 Apr; 51(7):941-7. PubMed ID: 8651944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
    Balzarini J; Herdewijn P; De Clercq E
    J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
    Ahluwalia GS; Gao WY; Mitsuya H; Johns DG
    Mol Pharmacol; 1996 Jul; 50(1):160-5. PubMed ID: 8700108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
    Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
    J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil).
    Nimmagadda S; Mangner TJ; Lawhorn-Crews JM; Haberkorn U; Shields AF
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1987-93. PubMed ID: 19506865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil is dependent on EBV thymidine kinase.
    Kira T; Grill SP; Dutschman GE; Lin JS; Qu F; Choi Y; Chu CK; Cheng YC
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3278-84. PubMed ID: 11083627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
    Schinazi RF; Peters J; Sokol MK; Nahmias AJ
    Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell.
    Staschke KA; Colacino JM; Mabry TE; Jones CD
    Antiviral Res; 1994 Jan; 23(1):45-61. PubMed ID: 8141592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
    Klecker RW; Katki AG; Collins JM
    Mol Pharmacol; 1994 Dec; 46(6):1204-9. PubMed ID: 7808443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU).
    Morgenroth A; Deisenhofer S; Neininger M; Vogg AT; Glatting G; Kull T; Reske SN
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):305-16. PubMed ID: 18432182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and mode of inhibition of varicella-zoster virus by L-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase.
    Li L; Dutschman GE; Gullen EA; Tsujii E; Grill SP; Choi Y; Chu CK; Cheng YC
    Mol Pharmacol; 2000 Nov; 58(5):1109-14. PubMed ID: 11040060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry.
    Wiegand R; Wu J; Shields AF; Lorusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():64-70. PubMed ID: 22410089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.